The new Smart Box, which will provide 24/7 tracking visibility using any one of three different GPS tracking devices, can also be used to ship clinical drug substance and cell & gene therapies.

The configurable container also uses Marken’s own SENTRY device that offers location, temperature, movement, and shock as often as once per hour.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Marken CEO Wes Wheeler said: “Marken has once again made the investments required to meet and exceed our customers’ expectations for shipment security and visibility.

“At least 1,000 new Marken Smart Box containers are scheduled for delivery to various Marken locations starting this month. At the same time, we are increasing our fleet of Sentry GPS tracking devices and have placed additional orders for thermal packaging to supplement the new Smart Box.”

It is built with rugged durability and can also accommodate Bluetooth technology for temperature monitoring as well as identification.

The Smart Box meets ISTA 3A qualified distribution testing for payload integrity and performance and has been thermal tested in compliance with industry standards for up to 96 hours at 2-8 degrees C.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The green colouration of the box offers recognition and easy identification.

Wheeler further added: “The combination of our existing fleet of thermal packaging and our new fleet of Smart Box containers, together with a variety of GPS trackers, will give our clients many options to secure and protect their valuable shipments.”

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact